IGF1 and acromegaly: It should be also emphasized that even if pasireotide-LAR treatment did not result in GH and IGF-1 levels normalization, a significant alleviation of acromegaly-related symptoms such as headache, impaired functioning, fatigue, excessive sweating, joint pain, and paresthesia, was observed.